Aanjaneya Lifecare has received the certificate of suitability from the European market for two of its bulk drugs Quinine sulphate and Quinine hydrochloride. The company has also bagged orders worth Rs 60 crore from Wockhardt, Cipla, Remedica, Tanzania Pharmaceutical, Activo SA and Pharmed Europe.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment